Michigan Biosciences Industry Association Logo

Federal Advocacy

Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
NIH Issues Rules Banning DEI Activities
Posted In: Federal Advocacy,
Date posted Apr 24

The National Institutes of Health (NIH) has implemented new grant policies that prohibit funding for researchers and institutions engaged in...

Read Post
Amid Proposed Cuts, Commission Calls For $15B NIH Support
Posted In: Federal Advocacy,
Date posted Apr 11

A federal commission, in a new report, is calling for $15 billion in new financing to reinforce the United States’ biotech leadership amid...

Read Post
Pause in Tariff Implementation Welcomed by Medtech Sector
Posted In: Federal Advocacy,
Date posted Apr 11

AdvaMed, a national medical device trade organization, of which MichBio is a state affiliate, applauded in a press release, the Trump...

Read Post
New Report on Where NIH Funding Cuts Would Hit Hardest
Posted In: Federal Advocacy,
Date posted Apr 11

According to the Science and Community Impact Mapping Project (SCIMaP), proposed NIH funding cuts could lead to $16 billion in economic loss and...

Read Post
Michigan Life Science Organizations Visit Capitol Hill
Posted In: Federal Advocacy,
Date posted Apr 10

MichBio was back on Capitol Hill last week as part of the annual BIO Legislative Fly-In to discuss issues of paramount interest to the...

Read Post
Bill on USPTO-FDA Collaboration Reintroduced
Posted In: Federal Advocacy,
Date posted Mar 28

New Bill Aims to Strengthen USPTO-FDA Collaboration A bill titled “The Interagency Patent Coordination and Improvement Act,” or S....

Read Post
Bill to Reauthorize the Rare Pediatric Disease PRV Program Introduced
Posted In: Federal Advocacy,
Date posted Mar 27

Bipartisan Effort Revives Rare Pediatric Disease Program The bipartisan “Give Kids a Chance Act of 2025”, or H.R. 1262, was...

Read Post
MichBio Continues to Push Back on Proposed NIH Cuts
Posted In: Federal Advocacy, MichBio News/Statement,
Date posted Mar 27

Defending Biomedical Innovation Amid NIH Budget Threats MichBio, along with numerous other bio-industry groups, continues to press Congress and...

Read Post
MichBio Heads to Capitol Hill for Biotech Advocacy
Posted In: Federal Advocacy, MichBio News/Statement,
Date posted Mar 27

MichBio to Visit Capitol Hill and Discuss Biotech/Pharma Issues MichBio is heading back to Capitol Hill on April 1 and 2 as part of the annual...

Read Post
The Department of Health and Human Services to Make Significant Workforce Cuts
Posted In: Federal Advocacy,
Date posted Mar 27

Major Changes at HHS: Workforce Cuts, Reorganization, and New Leadership The Department of Health & Human Services (HHS) announced 10,000 job...

Read Post
MichBio Talks Medtech with Michigan Congressional Delegation
Posted In: Federal Advocacy,
Date posted Mar 4

Join MichBio in advocating for the medtech industry! Discover our initiatives, events, and membership benefits to support innovation in Michigan's...

Read Post
NIH Indirect Cost Cuts Risks U.S. Leadership in Life Science Innovation
Posted In: Federal Advocacy,
Date posted Mar 4

Discover how NIH funding cuts threaten U.S. leadership in life science innovation. MichBio advocates for research sustainability and economic growth.

Read Post